Launch of Patient Advisory Board based on Patient’s Views and Progress

Despite the high prevalence of asthma respiratory allergies and chronic rhinosinusitis in Europe and the impact it has on patients quality of life, there remains a major unmet need to have the patient’s voice heard. The expert teams at EUFOREA launched a very active Patient Advisory Board with real patients that are willing to join forces with all stakeholders involved in respiratory care to optimize that care.

The goal of the Patient Advisory Board is to better understand the needs of the patients, the emotional and financial impact of the illness and to raise awareness at a political level whilst working on novel solutions for timely access to treatments.